Safety and efficacy of hypofractionated stereotactic radiosurgery for high-grade gliomas at first recurrence: a single-center experience

HIGHLIGHTS

• who: Yun Guan from the University, Wulumuqi Road (M), Shanghai, China have published the research: Safety and efficacy of Hypofractionated stereotactic radiosurgery for high-grade Gliomas at first recurrence: a single-center experience, in the Journal: (JOURNAL)
• what: The authors showed a median OS after HSRS of 17.6 months (19.5 and 14.6 months for grade 3 and 4 gliomas, respectively; p=0.039). The study demonstrates promising survival and mild toxicity using CyberKnife radiosurgery for rHGG patients.

SUMMARY

The most frequently diagnosed malignant primary brain tumour in adults . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.